🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Emory hematology and medical oncology fellow Maroun Bou Zerdan, MD, is presenting his work, “Prognostic relevance of Aurora kinase A (AURKA) expression in prostate cancer” in this morning’s #ASCO25 poster session.

🔥🚨OncoAlert Hot Off The Press Just published Journal of Clinical Oncology in conjunction with presentation ASCO #ASCO25 ✅Results of #NeoADAURA trial of: #Neoadjuvant #Osimertinib + Chemo Vs #Osimertinib Vs #Chemo in #Resectable #EGFR+ stage II–IIIB non-small-cell #LungCancer. 👇🏻

🔥🚨OncoAlert Hot Off The Press Just presented ASCO #ASCO25 by the amazing Luis Paz-Ares ✅Results of #IMforte trial of: #Lurbinectedin + #Atezolizumab as 1st line #Maintenance Tx in #Patients with #ExtensiveStage #SmallCell #LungCancer. 👇🏻

🔥🚨1/2 OncoAlert Hot Off The Press. Just presented ASCO #ASCO25 by the amazing Dr #Rudin Results of ⭐️#DeLLphi304 trial of: ✅#Tarlatamab vs #Chemotherapy in 2nd line #Treatment for #Patients with advanced #SmallCell #LungCancer. ‼️# Publication NEJM in prior post 👇🏻

Funny how two of the more interesting pieces of data at #ASCO25 have little to do with extraneous medications per se, but rather the body’s circadian rhythm and physiology: 1: Exercise after surgery 2: Checkpoint inhibitors in the morning

Another option for patients!! On June 11, 2025, the FDA approved taletrectinib (Ibtrozi, Nuvation Bio Inc.), a kinase inhibitor, for adults with locally advanced or metastatic ROS1-positive NSCLC. Full prescribing inf for Ibtrozi will be posted on Drugs@FDA.

Stem cell transplant showing promising treatment for type 1 diabetes mellitus.

Even the admin of this account is a joke 😆.

Nothing in this life is guaranteed. This past week has been heavy…. bad news among family, friends, and hearing about Diogo Jota’s passing. Life is fragile. Embrace the people you love. Hold onto every moment. Tomorrow is never promised.

That’s it, that’s the tweet.

Targeted Therapies Broaden Treatment Options for CDK4/6 Inhibitor–Resistant, HR+ Breast Cancer Kevin Kalinsky, MD, MS, FASCO Winship Cancer Institute of Emory University Emory University #bcsm #oncology onclive.com/view/targeted-…

FIFA CLUB WORLD CUP WINNERS!!! 🏆

Ici c’est SW17 Chelsea FC #WeWonItAll 💙💙💙💙💙💙💙💙💙💙💙💙💙💙💙💙💙💙💙💙💙💙💙💙💙💙💙💙💙💙💙💙💙

📸PHOTO DUMP: President Donald J. Trump at the FIFA Club World Cup Final 🇺🇸

The perfect pass. The perfect finish. #FIFACWC